Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology | Zendy

Ediléia Bagatin | Zendy; Caroline Sousa Costa | Zendy; Marco Rocha | Zendy; Fabíola Rosa Picosse | Zendy; Cristhine Souza Leão Kamamoto | Zendy; Rodrigo Pirmez | Zendy; Mayra Ianhez | Zendy; Hélio Amante Miot | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology

Author(s) -

Ediléia Bagatin,

Caroline Sousa Costa,

Marco Rocha,

Fabíola Rosa Picosse,

Cristhine Souza Leão Kamamoto,

Rodrigo Pirmez,

Mayra Ianhez,

Hélio Amante Miot

Publication year - 2020

Publication title -

anais brasileiros de dermatologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.461

H-Index - 44

eISSN - 1806-4841

pISSN - 0365-0596

DOI - 10.1016/j.abd.2020.09.001

Subject(s) - medicine , dermatology , isotretinoin , rosacea , acne , acitretin , adverse effect , psoriasis , pharmacology

Isotretinoin is a synthetic retinoid, derived from vitamin A, with multiple mechanisms of action and highly effective in the treatment of acne, despite common adverse events, manageable and dose-dependent. Dose-independent teratogenicity is the most serious. Therefore, off-label prescriptions require strict criteria.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research